Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Sales (2020 - 2025)

Journey Medical (DERM) has disclosed Return on Sales for 6 consecutive years, with 0.14% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales rose 3.0% year-over-year to 0.14%, compared with a TTM value of 0.15% through Sep 2025, up 33.0%, and an annual FY2024 reading of 0.26%, down 20.0% over the prior year.
  • Return on Sales was 0.14% for Q3 2025 at Journey Medical, up from 0.25% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.5% in Q4 2023 and bottomed at 1.24% in Q4 2021.
  • Average Return on Sales over 5 years is 0.34%, with a median of 0.31% recorded in 2025.
  • Peak annual rise in Return on Sales hit 117bps in 2023, while the deepest fall reached -77bps in 2023.
  • Year by year, Return on Sales stood at 1.24% in 2021, then skyrocketed by 46bps to 0.67% in 2022, then surged by 175bps to 0.5% in 2023, then tumbled by -77bps to 0.12% in 2024, then crashed by -217bps to 0.14% in 2025.
  • Business Quant data shows Return on Sales for DERM at 0.14% in Q3 2025, 0.25% in Q2 2025, and 0.31% in Q1 2025.